Zoetis Earnings
NYSE: ZTSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:03 PM ET · Delayed 15 min
Next earnings date
Thu, Nov 5, 2026
Before market open
Fiscal period
Sep/2026
EPS estimate
$1.52
Zoetis earnings summary
Zoetis is scheduled to report Sep/2026 earnings on Nov 5, 2026 before the market opens, with analysts expecting EPS of $1.52. In its most recent report on Aug 6, 2026 (Q2 2026), ZTS posted EPS of $1.65. Revenue for the quarter was $2.47 billion.
Quarterly EPS is up 1.2% from the same quarter a year earlier. Across the last 16 reports, ZTS shares moved an average of 3.5% (in either direction) in the first trading session after results, rising 10 times and falling 6 times.
Summary generated from market data by MetaCap's automated system. Methodology
ZTS earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 6, 2026 | — | $1.65 | — | +1.6% |
| May 7, 2026 | — | $1.42 | — | -10.4% |
| Feb 12, 2026 | — | $1.42 | — | +1.7% |
| Nov 4, 2025 | — | $1.63 | — | +0.5% |
| Aug 5, 2025 | — | $1.63 | — | +4.6% |
| May 6, 2025 | — | $1.34 | — | +2.4% |
| Feb 13, 2025 | — | $1.29 | — | +1.9% |
| Nov 4, 2024 | — | $1.50 | — | -1.0% |
| Aug 6, 2024 | — | $1.37 | — | -0.8% |
| May 2, 2024 | — | $1.31 | — | +1.2% |
| Feb 13, 2024 | — | $1.14 | — | +4.7% |
| Nov 2, 2023 | — | $1.29 | — | +4.4% |
| Aug 8, 2023 | — | $1.45 | — | -4.9% |
| May 4, 2023 | — | $1.19 | — | -1.4% |
| Feb 14, 2023 | — | $0.98 | — | -3.3% |
| Nov 3, 2022 | — | $1.13 | — | +11.1% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.